Source: National Institute of Allergy and Infectious Diseases Related MedlinePlus Topics: Asthma, H1N1 Flu (Swine Flu)
Teva Announces Approval And Launch Of Tri-Lo Sprintec Tablets
Posted by jeni 142 days ago (http://www.medicalnewstoday.com)
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market a generic version of Ortho McNeil Janssen's oral contraceptive, Ortho Tri-Cyclen® Lo. Shipment of this product, for which Teva's trade name is Tri-Lo Sprintec, has commenced.
Incisive Surgical, Inc. announced that it will launch a significantly more user-friendly next generation version of its INSORB Absorbable Skin Stapler at the Annual Meeting of the American College of Obstetricians & Gynecologists being held in Chicago from May 4 - 6, 2009. The INSORB(R)|25 Skin Stapler is a patented medical device that places an absorbable staple underneath the skin to close surg
« previous1 next »
Disscusion boards licensed and powered by ZoneX v3.3.1 Development supported by LifeForm Inc.
All Rights Reserved by SteadyHealth.com
© 2004 - 2009
This site complies with the HONcode standard for trustworthy health information:
verify here.
